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Abstract
Background: Human Immunodeficiency Virus 1 enters host cells through interaction
of its V3 loop (which is part of the gp120 protein) with the host cell receptor CD4 and
one of two co-receptors, namely CCR5 or CXCR4. Entry inhibitors binding the CCR5
co-receptor can prevent viral entry. As these drugs are only available for CCR5-using
viruses, accurate prediction of this so-called co-receptor tropism is important in order
to ensure an effective personalized therapy. With the development of next-generation
sequencing technologies, it is now possible to sequence representative
subpopulations of the viral quasispecies.
Results: Here we present T-CUP 2.0, a model for predicting co-receptor tropism. Based
on our recently published T-CUP model, we developed a more accurate and even
faster solution. Similarly to its predecessor, T-CUP 2.0 models co-receptor tropism using
information of the electrostatic potential and hydrophobicity of V3-loops. However,
extracting this information from a simplified structural vacuum-model leads to more
accurate and faster predictions. The area-under-the-ROC-curve (AUC) achieved with
T-CUP 2.0 on the training set is 0.968 ± 0.005 in a leave-one-patient-out
cross-validation. When applied to an independent dataset, T-CUP 2.0 has an improved
prediction accuracy of around 3% when compared to the original T-CUP.
Conclusions: We found that it is possible to model co-receptor tropism in HIV-1 based
on a simplified structure-based model of the V3 loop. In this way, genotypic prediction
of co-receptor tropism is very accurate, fast and can be applied to large datasets
derived from next-generation sequencing technologies. The reduced complexity of
the electrostatic modeling makes T-CUP 2.0 independent from third-party software,
making it easy to install and use.
Background
The Human Immunodeficiency Virus 1 (HIV-1) enters host cells by binding to the CD4
receptor and one of the chemokine co-receptors CCR5 and CXCR4, [1]. The so-called co-
receptor tropism of an HIV-1 virus describes the type of co-receptor that is being used:
those viruses binding specifically to the CCR5 receptor are called “R5”-, and those binding
to CXCR4 are called “X4”-tropic. Some viruses are able to bind either of the co-receptors
and are called “dual”- or “R5X4”-tropic. It has been shown that patients harboring X4-
tropic viruses tend to progess faster towards the Aquired Immunodeficiency Syndrome
(AIDS) when compared to patients harboring only R5-tropic viruses [2]. Recently devel-
oped drugs, such as Maraviroc [3] and Vicriviroc [4], specificially bind to the CCR5
receptor, effectively inhibiting viral entry of R5-tropic viruses. Unfortunately, these drugs
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are of course ineffective against X4-tropic viruses. Therefore reliable determination of
co-receptor tropism is crucial for an effective antiviral treatment of patients. Research
has focused on the development of both in vitro tests, such as cell-based assays on the
one hand, and in silico methods, on the other to develop a reliable tool for co-receptor
tropism determination. The main drawbacks of the former are rather high costs and long
turn-around time.
Most of the computational methods focus on the third variable loop (V3), a variable
region of the glycoprotein 120 (gp120) of HIV-1. V3 is around 35 amino acids in length,
variable in its sequence composition but also in length, and has been shown to be the
main determinant for co-receptor tropism [5]. Electrostatic interactions have been impli-
cated to play a decisive role in co-receptor tropism. The most simple and best-known
model of co-receptor usage is the 11/25 rule [6] predicting a virus to be R5-tropic unless
one of the amino acids sidechains at position 11 or 25 is positively charged. Although hav-
ing a high specificity (about 90%), this rule lacks sensitivity (40-60%). In order to improve
prediction accuracy, several more sophisticated prediction models, ranging from artifi-
cial neural networks [7], position specific scoring matrices [8] to support vector machines
[9] have been developed. In our recent studies, we have taken up the implication made
by charge-based rules (11/25) and developed an electrostatic hull approach to predict co-
receptor tropism [10]. In our approach, V3 sequences (from the training set as well as
sequences from new patients) are first modeled onto the V3 X-ray structure by Huang
et al. [11] (PDB:2b4c). Second, the electrostatic potential φ(r) around the V3 loops is esti-
mated by calculating the electrostatic potential on a constant hull, a discretized surface
of nhull = 642 points in an approximate distance of 0.6 nm around the solvent accessible
surface of the V3 structure. The electrostatic hulls of the V3 loops are then used as input
for a random forest model [12]. In addition, we complemented the structural electrostatic
descriptor with a sequence-based classifier, the hydrophobicity scale by Kyte andDoolittle
[13], which encodes amino acid sequences with numerical values representing their
hydrophobicity. The hydrophobicity descriptor has been used in several other studies and
a wide range of applications leading to accurate predictions [14-19]. The electrostatic and
hydrophobicity classifiers, are then combined by a second-level-learning approach [20],
i.e. the outputs of the two classifiers are used as an input for a third random forest, making
the final prediction. With this scheme, we outperformed the prediction accuracy of other
state-of-the-art methods, such as geno2pheno [21] and wetcat [9], as demonstrated on an
independent test set [10]. Introducing structural information into classification models
seem to improve overall prediction performance [10,22-24]. The combination of struc-
tural and sequence information has not only been demonstrated in HIV-1 co-receptor
usage prediction, but also in other related studies dealing with HIV-1 drug resistance pre-
diction [25,26]. For instance, Hou et al. developed an SVM-based method that modeled
HIV-1 protease inhibitor resistance using structural information of the HIV-1 protease
[25]. We proposed a classification model for Bevirimat resistance in HIV-1 that combines
sequence-derived and structural information of the viral p2 protein [26]. These studies
suggest that the combination of sequence and structural information can improve predic-
tion performance, compared to classifiers based on either sequences or structures. This
is in line with theoretical findings that ensemble learning can lead to better prediction
results and that classifier diversity is highly important [27]. The rather complex model-
ing and prediction scheme of our initial co-receptor prediction method (called T-CUP)
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leads to disadvantages in computation speed, and involves a handful of external programs.
Thus, to date T-CUP has not been available. The aim of this study was the development of
T-CUP 2.0, a less complex and faster method, that yields better or comparable predictive
power and is easy to install and to use.
Methods
Data
For this study, we used the data gathered by Dybowski et al. [10]. It consists of 1351
clonal amino acid sequences of the V3 loop of HIV-1 from 899 patients. 200 sequences are
derived from X4-tropic (34 R5X4, 166 X4) viruses and 1151 from R5-tropic viruses. Most
of the sequences are from subtype B (~52%), subtype C (~17%) and subtype D (~9%).
However, 22% of the sequences spread over many different subtypes. Sequences, tropism
and subtype information was extracted from the Los Alamos HIV database (http://www.
hiv.lanl.gov/).
Sequence Interpolation
All sequences were transformed to a uniform length of 35 and encoded by the numer-
ical hydropathy descriptor using the Interpol package [28] of R [29]. Interpol uses a
numerical representation of the amino acids (here: hydropathy) and concatenates these
data points. From the resulting curve samples are taken by equal interval. These samples
are then used as features for classification.
Linear interpolation on a set of data points (x0, y0), (x1, y1), . . . , (xn, yn) is defined as
the concatenation of linear interpolants between each pair of successive data points. The
normalization factor is defined as the number of samples taken (by equal interval) from
the aforementioned curves to generate an input for the subsequent classification. Here we
used a normalization factor of 35.
Clustering
In the V3 model, the datapoints were clustered using the k-Means algorithm in R. The
number of centers was set to 35.
Machine Learning
Random forests [12] were used for developing a classification model, as implemented
in the randomForest package [30] of R. Receiver operating characteristics (ROC)
curves were calculated and analyzed using the ROCR package [31]. Cross-validation
was performed based on a leave-one-patient-out scheme according to Dybowski et al.
[10], where the random forest was trained on all sequences of all patients except one
patient, and the tropisms of the sequences of the remaining patient were predicted.
This was repeated for each patient. This patient-wise-cross-validation was repeated for
10 times to average prediction performance. Area under the curve (AUC) values are
shown as a ± δ, marking the average and the 95% confidence interval estimated with
a t-distribution. Feature importance was assessed using the built-in function of the
randomForest package and estimated by the sum of all decreases in Gini impurity,
which has been shown to be more robust compared to the mean decrease in accu-
racy [32]. For statistical comparison we used Wilcoxon signed-rank test on the AUC
distributions.
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Diversity
Classifier diversity has been shown to play an important role in classifier ensembles. Thus,
we calculated classifier diversity in two ways. First, diversity was calculated based on the
Spearman correlation between the classifier outputs oi and oj of classifier i and j for all
samples k ∈ {1, . . . , n}. Second, we measured the disagreement of classifier i and j, i.e.
Di,j = 1n ·
n∑
k=1
|oik − ojk| (1)
Comparison with other methods
For comparison with other prediction methods, we used the independent testset of
Dybowski et al. [10]. This testset consists of 74 sequences from different HIV-1 subtypes.
We compared T-CUP 2.0 with geno2pheno [21], wetcat [9] and the recently developed




The motivation for a new prediction model for HIV-1 co-receptor usage is that T-CUP
has a very high accuracy, but is rather slow due to the modeling process of the V3 loops
with Modeller [33] and the calculation of the electrostatic hull with APBS [34]. This is
especially important for new sequencing technologies, i.e. next-generation sequencing,
where millions of sequences are generated per sample and fast predictions are needed
to be applicable in routine diagnostics. Albeit T-CUP has been demonstrated to be
applicable to next-generation sequencing data [35] in principle, it lacks computational
efficiency. Therefore, we decided to develop a novel structural descriptor that is both,
highly accurate with regard to subsequent classification, but also very efficient with regard
to computing time.
The original T-CUP electrostatic classifier was based on an ESP hull above the
V3 loop surface. Discretized values of the potential were used to predict co-receptor
usage. However the calculation of these electrostatic potential values required solving
the Poisson-Boltzmann equation (PBE), which is computationally expensive. The dis-
cretized ESP values are the result of charges found on the V3 loop and change when
different values for the permittivity of these charges are assumed. In our original pub-
lication, we tested different values for permittivity for the solvent and protein. We
found that the T-CUP electrostatic model has a good accuracy for a dielectric con-
stant of 5 inside and outside the protein and an ionic strength of zero. Although these
values do not reflect physiological conditions, the prediction accuracy was best. For
T-CUP 2.0, we exploit the fact that under these conditions (equal permittivity of solvent
and protein) the Poisson-Boltzmann equation can be reduced to a potential based on
Coulomb’s law.
In our new model, in the following referred to as T-CUP 2.0, coordinates of the Cα
atoms of the V3 structure of Huang et al. [11] were used as the basis for model build-
ing. First, V3 sequences were encoded with Interpol [28] using the net charge descriptor
[36] and transformed to 35 values. For each sequence, the interpolated charge values were
assigned to the template Cα coordinates. In this way, we can simplify the solution for the
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NP-hard side-chain packing problem [37] faced during the modeling step of the original
T-CUP [10]. Next, the V3 structure was placed into a three-dimensional grid with a spac-
ing of 1. Grid points that lay within a distance of [5,6] to any of the Cα were extracted.
The resulting 8372 points were reduced by k-Means clustering (k = 35). Here, k was set
to match the number of Cα atoms present in the model and thus serving as cluster cen-
ters. In the last step, the electrostatic potential (φ(xi)) for each of the cluster centers xi
was calculated by a vacuum model.
Our idea is based on our findings [10] that the T-CUP electrostatic model has a good
accuracy for a dielectric constant of 5 inside and outside the protein and an ionic strength
of zero. Under these conditions, the Poisson-Boltzmann equation can be reduced to a





















The resulting φ(xi) values were then used as a descriptor for the classifier, similar to the
ESP values in the former model [10].
Second-level classification
Besides the electrostatic vacuum model, we also trained a classifier using the hydropathy
scale according to Dybowski et al. [10]. The V3 sequences were encoded and interpolated
to a length of 35 using Interpol [38]. The outputs of the vacuummodel and the hydropathy
model were then combined via stacking according to Dybowski et al. [10].
Performance
Using a patient-wise cross-validation scheme (see Methods) we demonstrated that T-
CUP 2.0 performs superior compared to T-CUP with regard to prediction performance.
ROC curves shown in Figure 1 show that T-CUP reaches an AUC of 0.937 ± 0.004 and is
surpassed by T-CUP 2.0 with AUC of 0.968 ± 0.005 (p < 0.0001). We additionally evalu-
ated the performance on an independent test set that has been compiled from literature
by Dybowski et al. [10] and consists of 74 V3 sequences, including R5-, X4- and R5X4-
tropic viruses. T-CUP 2.0 outperformed T-CUP also on this test set as shown in Table 1
(We calculated the sensitivities at certain specificities for the different algorithms). For
instance, T-CUP 2.0 reaches a sensitivity of 85% at a specificity of 95% (i.e. a false positive
rate of 5%), whereas T-CUP only achieves a sensitivity of 73% at a specificity of 95%.
Importance analysis
Besides producing accurate predictions, random forests can also be used to estimate
the importance of features used in the model. To this end, we calculated the sum of all
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Figure 1 ROC curves. Comparison of T-CUP [10] (red) and T-CUP 2.0 (green) based on the patient-wise-cross-
validation.
decreases in Gini impurity for each cluster in the vacuum model. The results are shown
in Figure 2. The most important clusters (importance > 10) in the vacuum model are 7,
8, 12, 14, 20, 21, 24, 27, 29 and 35. These positions are close to sequence positions 11 and
25 in the V3 structure and hence are in line with the findings from Dybowski et al. [10],
who also predicted the most important regions of the electrostatic hull to be around these
positions. Furthermore, these findings agree with the 11/25 rule. The clusters are not
exactly at position 11 and 25 due to the modeling process, as they represent grid points
and not the atoms in the structure.





T-CUP 2.0 0.70 0.98
Bozek et al.* 0.75* 0.96*
T-CUP 0.73 0.95
Bozek et al. 0.81 0.95
T-CUP 2.0 0.85 0.95
T-CUP 0.81 0.83
Bozek et al. 0.94 0.83
T-CUP 2.0 0.95 0.83
Methods are evaluated on an independent test set of 74 sequences collected from the literature with experimentally
validated tropism. *:The method of Bozek et al. does only provide results for a specificity ≤ 0.96.
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A B
Figure 2 Importance analysis. A: Importance for each cluster for the classification process, measured as
sum of all decreases in Gini impurity. Highly important clusters (importance > 10) are colored in red.
B: Clusters are shown as spheres in the V3 crystal structure. Highly important clusters (importance > 10) are
shown as red spheres.
Diversity analysis
We then measured the diversity of the two first level classifiers, namely the vacuum and
the hydropathy model in two ways: We calculated Spearman’s rank correlation coefficient
ρ of the predicted X4-probabilities of the training samples, and the disagreement of the
two classifiers. The correlation of the two classifiers in T-CUP 2.0 is ρ = 0.6381±0.0009.
For comparison, the correlation of T-CUP, namely the correlation of the ESP and the
hydropathy classifiers is ρ = 0.6096. The disagreement measure in T-CUP 2.0 is D =
0.0662 ± 0.0003 and 0.0752 in T-CUP. Thus, the diversity is slightly higher in T-CUP
compared to T-CUP 2.0. This is visualized in the prediction landscape for T-CUP 2.0 as
shown in Figure 3. The fact that the diversity of T-CUP is slightly higher compared to T-
CUP 2.0 is unexpected as the overall performance of T-CUP 2.0 is higher. In contrast to
the assumption that a higher diversity within a classifier ensemble leads to a better pre-
diction, T-CUP 2.0 demonstrates the opposite. Nevertheless, the diversity is only slightly
decreased and this seems to have no negative effect to the prediction accuracy.
Template analysis
We took V3 loops from two X-ray structures as templates, both with V3 in the context
of CD4 bound gp120 and an antibody, to test whether the template structure of the V3
loop has an impact on the classification performance. First the V3 structure from PDB
entry 2b4c [11] was used, based on the R5-tropic strain JR-FL and bound to antibody X5.
For the second round we used V3 from PDB entry 2qad [39], based on R5-tropic strain
YU2 and complexed with the sulfated antibody 412d. The latter V3 structure is less open
in the central bulge region of V3 as it there binds one of the sulfate groups. Both V3
sequences have a length of 35 amino acids and carry only three conservative mutations.
Surprisingly, using a more recent V3 structure [39], we found no significant differences in
AUC distributions according to the Wilcoxon signed-rank test (p = 0.25). Moreover, we
also tested a model that, besides hydrophobicity and charge, employs the length of the V3
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Figure 3 Prediction landscape of T-CUP 2.0. On the x-axis the prediction probability for a virus being X4 for
the vacuummodel is shown. On the y-axis the corresponding probability of the hydropathy model is shown.
The colorscale shows the final X4-probability of T-CUP 2.0. The more red, the higher the X4-probability.
sequences. This is motivated by the notion that the sequence length in the training set is
rather narrowly distributed in R5-tropic (83% have length of 35 amino acids), while being
broader in X4-tropic viruses (only 52.5% have length of 35 amino acids). However, incor-
porating length information into the classification system did not improve classification
performance (Wilcoxon signed-rank test p = 0.44).
Evaluation on NGS data
Both algorithms, T-CUP andT-CUP 2.0 have a linear computational complexity (inO(n)).
T-CUP 2.0 is completely written in R and up to 14-times faster than the original T-CUP.
For data resulting from a 454/Roche GS FLX sequencing run and consisting of around
1 million reads, T-CUP 2.0 needs 3.1 days on a single CPU, while T-CUP requires 43.7
days. Both systems can be run in parallel, leading to around 9 hours for T-CUP 2.0 (two
Quadcore server with IntelXeon(R) CPU E5462 @ 2.80GHz and 32GB RAM), and five
days for T-CUP still.
We also evaluated the performance with real next-generation sequencing data taken
from Tsibris et al. [40] and compared the prediction of T-CUP 2.0 with the results from
phenotypic assays. The next-generation sequencing data was generated from samples
of four patients at three timepoints during treatment with the co-receptor antago-
nist Vicriviroc. Additionally, phenotypic tropism predictions were acquired at several
timepoints. All patients had R5-tropic viruses at treatment start, but experiences ther-
apy failure after a few weeks into treatment. We extracted the V3 sequence from the
next-generation sequencing reads according to Dybowski et al. [35] and predicted the
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X4-fraction of each time point with T-CUP 2.0. As for the old model T-CUP [35], the
predicted X4-fractions are perfectly in line with the results from the phenotypic assays
(see Figure 4).
Conclusions
T-CUP 2.0 performs superior compared to T-CUP in both, the patient-wise cross-
validation and on the independent test set. When comparing prediction results between
T-CUP 2.0 and T-CUP the correlation is relatively high r = 0.702 ± 0.001. The dis-
agreement D = 0.1001 ± 0.0014, indicates that classifiers can be combined into a
final, more accurate prediction. Also Chueca et al. [41] have suggested to combine dif-
ferent prediction models to improve overall prediction performance. Additionally, we
have demonstrated the use of our method with next-generation sequencing data. The
predicted X4-fraction is in agreement with results obtained from phenotypic assays.
However, computational method such as T-CUP 2.0 are able to detect smaller fractions
of X4-viruses compared to current phenotypic assays and thus should be considered as
more sensitive for diagnostics issues with next-generation sequencing data [42]. Finally,
Figure 4 Development of X4-fraction. Development of predicted fraction of X4-using viruses during
treatment. Labels “R5” (R5-using) and “DM” (dual/mixed or X4-using) are Trofile results at the given times. The
dotted line marks the 10% detection rate of standard Trofile assay. The black dots represent the time points
when the NGS data was sampled, the solid lines are used for visualization of the fraction of X4-using viruses
between these measured data points.
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we are convinced that making the T-CUP 2.0 R-package available to other researchers is
a valuable contribution to the field.
Availability and requirements
Project name: T-CUP 2.0
Project home page: http://www.uni-due.de/~hy0546/TCUP2.zip
Operating system(s): cross-platform (64bit architecture)
Programming language: R
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